NCT04179331View on ClinicalTrials.gov

Neurotensin Infusions in Healthy Individuals -

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

January 23, 2020

Study Completion Date

January 23, 2020

Conditions
Healthy
Interventions
OTHER

Neurotensin

Neurotensin is an endogenous peptide released from the distal small intestine. It will be administered at three doses (2.5, 5.0 and 7.5pmol/kg/min), each for 1h, in sequence.

OTHER

Saline

Isotonic saline will serve as a placebo.

Trial Locations (1)

2650

hvidovre Hospital, Hvidovre

All Listed Sponsors
collaborator

Hvidovre University Hospital

OTHER

lead

University of Copenhagen

OTHER

NCT04179331 - Neurotensin Infusions in Healthy Individuals - | Biotech Hunter | Biotech Hunter